Mealey's (September 5, 2019, 2:41 PM EDT) -- LAS VEGAS — A federal judge in Nevada on Aug. 26 remanded a lawsuit brought by patients who feared they became infected with hepatitis B, hepatitis C or HIV after receiving injections for propofol prior to colonoscopies performed at a clinic that reused injection syringes and anesthesia bottles, finding that it was not facially apparent that the plaintiffs sought more than $75,000 in damages and that their claim for punitive damages and request for attorney fees did not demonstrate that the requested damages exceeded the jurisdictional threshold (Yvette Adams, et al. v. Teva Parenteral Medicines Inc., et al., No. 18-cv-02305-GMN-BNW, D. Nev., 2019 U.S. Dist. LEXIS 145131)....